Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Access expired on Saturday, August 31, 2024

This content was originally shared by a registered user, but access has expired. Create a free account to gain permanent access to all PracticeUpdate content.

Already Have An Account? Log in Now

featured

Journal Scan / Research · July 24, 2024

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide

JAMA Ophthalmology

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Ophthalmology
Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide
JAMA Ophthalmol 2024 Jul 03;[EPub Ahead of Print], JT Hathaway, MP Shah, DB Hathaway, SM Zekavat, D Krasniqi, JW Gittinger, D Cestari, R Mallery, B Abbasi, M Bouffard, BK Chwalisz, T Estrela, JF Rizzo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading